InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Robert J Gould, Director, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 12 open-market SEC Form 4 transactions: 0 purchases worth $0 and 12 sales worth $4.1M, reported from Apr 1, 22 to Feb 2, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 2, 26 | FULCFulcrum Therapeutics, Inc. | SELL | 15.0K | $10.72 | $161K |
| Jan 2, 26 | FULCFulcrum Therapeutics, Inc. | SELL | 15.0K | $11.87 | $178K |
| Nov 19, 25 | FULCFulcrum Therapeutics, Inc. | SELL | 15.0K | $11.03 | $165K |
| Jan 13, 23 | FULCFulcrum Therapeutics, Inc. | SELL | 6.8K | $15.00 | $101K |
| Jun 7, 22 | FULCFulcrum Therapeutics, Inc. | SELL | 71.4K | $8.09 | $578K |
| Jun 6, 22 | FULCFulcrum Therapeutics, Inc. | SELL | 24.4K | $8.10 | $197K |
| Jun 3, 22 | FULCFulcrum Therapeutics, Inc. | SELL | 25.6K | $7.95 | $203K |
| Jun 2, 22 | FULCFulcrum Therapeutics, Inc. | SELL | 16.7K | $7.92 | $132K |
| Apr 7, 22 | FULCFulcrum Therapeutics, Inc. | SELL | 5.6K | $24.02 | $135K |
| Apr 5, 22 | FULCFulcrum Therapeutics, Inc. | SELL | 52.6K | $24.26 | $1.3M |
| Apr 4, 22 | FULCFulcrum Therapeutics, Inc. | SELL | 7.2K | $24.02 | $174K |
| Apr 1, 22 | FULCFulcrum Therapeutics, Inc. | SELL | 34.5K | $24.03 | $828K |